HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $28 Price Target
MediWound Analyst Ratings
Analysts' Top Healthcare Picks: Checkpoint Therapeutics (CKPT), Mediwound (MDWD)
Buy Rating Affirmed for Mediwound: Strategic Alliances and Financial Infusions Signal Strong Market Position for EscharEx
Buy Rating for Mediwound Backed by Strong Revenue Growth and Solid Pipeline Prospects
MediWound Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Oculis Holding (OCS) and Mediwound (MDWD)
Analysts Are Bullish on Top Healthcare Stocks: Mediwound (MDWD), Ironwood Pharma (IRWD)
MediWound Analyst Ratings
Mediwound's EscharEx: A Buy Rating on Potential Market Disruption and Superior Clinical Performance
MediWound Analyst Ratings
Mediwound Poised for Growth: Buy Rating Affirmed Amidst FDA Progress, Revenue Forecasts, and Expansion Potential
Mediwound's Promising Outlook: Buy Rating Justified by Q3 Results and Expanding Market Opportunities
HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $26 Price Target
MediWound Analyst Ratings
Maxim Group Sticks to Their Buy Rating for Mediwound (MDWD)
HC Wainwright & Co. Maintains Buy on MediWound, Raises Price Target to $26
MediWound Analyst Ratings
Mediwound (MDWD) Receives a Buy From H.C. Wainwright
Maxim Group Sticks to Its Buy Rating for Mediwound (MDWD)